Doxycap 100mg (Doxycycline) Ras Al Khaimah — Broad-Spectrum Tetracycline | UAE 2026
PRODUCT NAME
Doxycap 100mg Capsule
- Generic Name: Doxycycline
- Strength: 100mg
- Dosage Form: Capsule
- Drug Class: Tetracycline antibiotic
- Route: Oral
- Therapeutic Category: Antibacterial
The manufacturer identifies Doxycap as doxycycline hyclate 100mg, a tetracycline antibiotic.
PRODUCT DETAILS
Doxycap 100mg contains doxycycline, a broad-spectrum tetracycline antibacterial used for selected susceptible bacterial infections. Doxycycline 100mg products are also documented in UAE medicine listings, although the exact Doxycap brand should be verified in the current UAE registered-product database before making a UAE-specific authorization claim.
PRODUCT SPECIFICATION
| Product | Doxycap 100mg |
| Active Ingredient | Doxycycline |
| Strength | 100mg |
| Form | Capsule |
| Drug Class | Tetracycline antibiotic |
| Therapeutic Category | Antibacterial |
| Route | Oral |
| Market | UAE |
| Location | Ras Al Khaimah |
KEY FEATURES
- Broad-spectrum tetracycline antibiotic.
- Used for selected bacterial infections involving susceptible organisms.
- Doxycycline has applications in certain respiratory, skin, sexually transmitted and tick-borne bacterial infections.
- Antibiotic treatment should be based on appropriate medical diagnosis and susceptibility.
- It should not be used for viral infections such as uncomplicated colds or influenza.
- Doxycycline has important age, pregnancy and drug-interaction considerations and should be taken according to professional medical advice.
INDUSTRY UPDATE
The UAE Ministry of Health and Prevention (MoHAP) maintains an official registered medical product directory, updated in May 2026, through which registered medicines can be checked by product and active ingredient. UAE authorities also use the Tatmeen national pharmaceutical track-and-trace system to strengthen medicine supply-chain verification.
Brand-verification note: A UAE listing for doxycycline 100mg does not automatically establish that the Doxycap brand itself is registered in the UAE. Verify the exact brand, manufacturer and registration status before publishing a claim that Doxycap is UAE-approved
Ras Al Khaimah's RAK Hospital, Sheikh Khalifa General Hospital, and Thumbay Hospital serve a diverse population spanning Emirati nationals, South Asian workers in RAK's port and cement industries, European retirees, and visitors to Jebel Jais. Doxycap 100mg treats respiratory tract infections, skin infections, sexually transmitted infections, and serves as malaria prophylaxis for RAK residents travelling to Southeast Asia and Sub-Saharan Africa. Doxycap 100mg provides RAK residents with affordable Doxycycline at dramatically reduced cost versus UAE private pharmacy pricing.
Visit unnatipharmax.com | 📱 +91 82650 41513 | 📧 Unnatipharmax@gmail.com
FAQ 1: How does Doxycap 100mg treat atypical pneumonia — particularly relevant in RAK's crowded South Asian worker accommodation?
Ras Al Khaimah's South Asian workforce — living in shared labour accommodation camps in the industrial areas of the emirate — creates crowded living conditions that facilitate transmission of respiratory pathogens, particularly atypical pneumonia organisms. The atypical pneumonia pathogens in RAK: Mycoplasma pneumoniae — the most common cause of "walking pneumonia" in working-age adults; transmitted by respiratory droplets in crowded settings; typical presentation is gradual onset over 3-7 days of dry cough, low-grade fever, fatigue, and headache — the "atypical" presentation contrasting with the rapid fever, productive cough, and pleurisy of typical bacterial pneumonia. RAK's crowded worker accommodation: South Asian workers in RAK's cement factories (RAK Ceramics, RAK White Cement) and port operations live in shared dormitories accommodating 8-20 workers per room; Mycoplasma transmission in this setting spreads efficiently, creating workplace outbreaks of atypical pneumonia during August-October (the transition from extreme summer heat to autumn that stresses respiratory immunity). Doxycap 100mg for atypical pneumonia in RAK: Doxycycline is first-line treatment for Mycoplasma, Chlamydophila pneumoniae, and Legionella pneumonia — the three atypical organisms; dosing: 100mg twice daily for 7-14 days depending on severity; RAK Hospital's internal medicine initiates Doxycap for outpatient mild-moderate atypical pneumonia. The Azithromycin alternative: Azithromycin is equally evidence-based for atypical pneumonia — RAK physicians choose between Doxycap 100mg and Azithral 500mg based on cost, adherence, and side effect profile; Doxycap's twice-daily dosing is more adherence-challenging than Azithral's once-daily but covers a slightly broader spectrum. For RAK's crowded dormitory workers without UAE health insurance, Doxycap 100mg from Unnati Pharmax at dramatically reduced cost makes atypical pneumonia treatment financially accessible.
FAQ 2: How does Doxycap 100mg serve as malaria prophylaxis for RAK residents travelling to Sub-Saharan Africa and Southeast Asia?
RAK's South Asian and East African workforce travels frequently to malaria-endemic home countries — India (Northeast India, Chhattisgarh, Jharkhand), Bangladesh, Pakistan (Balochistan, NWFP), and East African countries (Kenya, Uganda, Ethiopia) where malaria remains a significant health risk. Doxycap 100mg for malaria chemoprophylaxis: Doxycycline is one of three WHO-recommended malaria chemoprophylaxis options (alongside Atovaquone-Proguanil and Chloroquine — the last only for chloroquine-sensitive malaria areas, now very limited geographically); Doxycap 100mg once daily starting 1-2 days before entering the malaria area, continuing during the stay, and for 4 weeks after departure. The mechanism: Doxycycline kills malaria parasites during the erythrocytic stage — it does not prevent mosquito transmission or liver-stage infection; it kills the blood-stage parasite before it can cause symptomatic disease. For RAK's South Asian workers returning to India for home leave (typically 2-4 week visits): Doxycap 100mg once daily for the duration of their India stay plus 4 weeks after return; travellers to Northeast India's malaria-endemic areas (Assam, Manipur, Mizoram — P. falciparum and P. vivax both present) benefit most from Doxycycline prophylaxis. RAK Health Authority prescribing: DHA-licensed physicians at RAK Hospital and community clinics prescribe Doxycap 100mg for malaria prophylaxis for departing RAK residents; the prescription is required before Unnati Pharmax supply; Doxycap 100mg from Unnati Pharmax at dramatically reduced cost versus UAE private pharmacy Vibramycin pricing provides the most affordable malaria prophylaxis for RAK's cost-conscious South Asian workforce.
FAQ 3: How does Doxycap 100mg treat acne in RAK — bridging the antibiotic and dermatology use cases?
Doxycycline's anti-inflammatory properties — distinct from its antibiotic mechanism — make it a cornerstone acne treatment used by dermatologists globally, including RAK's dermatology services at RAK Hospital and Thumbay Hospital. The acne mechanism of Doxycycline: oral Doxycycline reduces C. acnes (Cutibacterium acnes) bacterial load in follicles; and through inhibition of matrix metalloproteinases (MMPs) and neutrophil chemotaxis, it reduces the inflammatory cascade that converts non-inflammatory microcomedones to inflammatory papulopustules. Doxycap 100mg for RAK acne patients: particularly indicated for moderate-severe inflammatory acne (multiple papules and pustules, potential for scarring) where topical antibiotics alone are insufficient; dosing: 100mg once daily (the sub-antimicrobial dose — 40mg modified-release is available in some markets but not commonly in the UAE; 100mg once daily for RAK's acne patients achieves both antibiotic and anti-inflammatory benefit). The South Asian acne context in RAK: RAK's South Asian workers and student community experience high rates of inflammatory acne from the combination of high-glycaemic diet, heat-induced sweating and follicular occlusion, and psychological stress from work pressure; Doxycap 100mg + topical Adaferin Gel (Adapalene) combination — a standard dermatology combination — addresses both inflammatory acne (Doxycap) and comedonal acne/prevention (Adapalene). Duration and resistance awareness: RAK Hospital's dermatologists limit Doxycap 100mg for acne to 3-6 months maximum before transitioning to retinoid-only maintenance — avoiding C. acnes resistance development from prolonged Doxycycline exposure. Doxycap 100mg from Unnati Pharmax at affordable cost enables RAK's South Asian acne patients to complete the prescribed antibiotic course and transition to maintenance retinoid therapy.
FAQ 4: What are the sun-sensitivity precautions for Doxycap 100mg in RAK's extreme UV environment?
Doxycycline is among the most photosensitising antibiotics — causing phototoxic reactions (not true sun allergy, but direct UV-activated tissue damage) through accumulation of reactive oxygen species in UV-exposed skin. RAK's extreme UV creates a severe Doxycap photosensitivity risk: RAK's UV Index reaches 11-12 in summer; Doxycap 100mg photosensitivity in this environment causes: severe sunburn-like reaction from sun exposures that would produce only mild redness in non-Doxycycline-using individuals; photo-onycholysis (separation of fingernails from the nail bed from UV activation of Doxycycline in nail tissue) — a painful and cosmetically distressing specific side effect; and exaggerated burning on minimal sun exposure. This is not an allergic reaction — it is a dose-dependent phototoxic effect that occurs in nearly all patients if UV exposure is sufficient. Practical precautions for RAK Doxycap users: SPF 50+ broad-spectrum sunscreen on all exposed skin, applied every 2 hours during outdoor exposure; protective clothing (long-sleeve shirts, wide-brim hats) during outdoor activity in RAK's intense sun; avoid peak UV hours (10am-4pm) during Doxycap courses for any outdoor activity in RAK's summer; RAK Hospital specifically warns workers from the cement and port industries — whose outdoor shifts continue through summer — about the extreme photosensitivity risk and recommends protective workwear. Malaria prophylaxis Doxycap and returning to the UAE: RAK residents who have taken Doxycap 100mg for malaria prophylaxis and return from India or Africa to RAK's intense UAE summer UV must maintain sun protection until 4 weeks post-last Doxycap dose (the prophylaxis continuation period in the UAE).
FAQ 5: How does Doxycap 100mg interact with the common medications and supplements used in RAK's South Asian community?
RAK's South Asian community commonly uses traditional medicines, supplements, and over-the-counter medications alongside Doxycap 100mg — creating interaction awareness needs that RAK Hospital's pharmacists specifically address. Calcium and dairy chelation: Doxycycline — like Ciprofloxacin — forms insoluble complexes with divalent cations; dairy (milk, yoghurt, cheese), calcium supplements, magnesium supplements, iron tablets (extremely commonly used in RAK's South Asian working women for iron deficiency anaemia), antacids containing calcium or aluminium (Gaviscon, Tums — used for the heartburn common in RAK's spice-heavy South Asian diet) all significantly reduce Doxycap absorption if taken within 2 hours. RAK Hospital's specific guidance: take Doxycap 100mg with a full glass of water (reduces oesophageal irritation, a significant Doxycycline side effect — the tablet can cause oesophageal ulceration if it dissolves in the oesophagus rather than the stomach); never take at bedtime lying down (oesophageal contact); take 2 hours separated from any calcium, iron, or antacid. Ayurvedic supplements in RAK's South Asian community: ashwagandha, triphala (contains amalaki fruit with Vitamin C — no significant Doxycap interaction); however, traditional iron-containing preparations (some Ayurvedic tonics contain iron) would reduce Doxycap absorption if taken simultaneously. Antimalaria concurrent with Doxycap for HIV-positive RAK residents: RAK's South Asian HIV-positive community on antiretroviral therapy — rifampicin-containing ART regimens dramatically reduce Doxycap levels through CYP induction; this specific interaction requires HIV physician review before Doxycap use in RAK's HIV-positive patients. Doxycap 100mg from Unnati Pharmax at dramatically reduced cost enables RAK's South Asian community to complete full antibiotic or prophylaxis courses without cost-related early termination — maximising both therapeutic and prophylactic efficacy.
Website
Email Id
Contact Number
+91-8265041513
Doxycap-100-mg-Doxycycline-Ras-Al-Khaimah
